TypeIV

Company Overview

Snapshot

Founded in February 2017 by Boaz Shetzer and Ziv Kalderon, TypeIV operates with 1–10 employees. The company is currently in a Pre-Funding stage.

Business overview

TypeIV is a wellness solution provider focused on assisting individuals with contact allergies. The company offers a service that translates complex medical information into actionable daily behaviors, simplifying the process of purchasing safe products. TypeIV has developed a mobile application that enables users to scan consumer products and identify ingredients they wish to avoid due to allergic reactions. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Therapeutics, serving markets such as the Americas, Japan, China, Germany, and the United States.

Company Intelligence Q&A

What is TypeIV's primary focus?

TypeIV specializes in providing wellness solutions for individuals managing contact allergies, offering tools to help them identify and avoid specific ingredients in consumer products.

When was TypeIV founded?

TypeIV was founded in February 2017.

Who are the founders of TypeIV?

TypeIV was co-founded by Boaz Shetzer, who serves as CEO, and Ziv Kalderon, the CTO.

What technology does TypeIV utilize?

TypeIV has developed a mobile application that allows users to scan consumer products for ingredient analysis, helping them verify the presence of substances they need to avoid due to allergies.

In which sectors does TypeIV operate?

TypeIV operates in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Digital Therapeutics.